Eris Biotech
American Fork
About Eris Biotech
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2024)
- Website: erisbio.com
Industries & Categories
Biopharma, Biotechnology, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/eris-biotech-96848 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.